545 related articles for article (PubMed ID: 18079394)
1. The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations.
Huang CH; Mandelker D; Schmidt-Kittler O; Samuels Y; Velculescu VE; Kinzler KW; Vogelstein B; Gabelli SB; Amzel LM
Science; 2007 Dec; 318(5857):1744-8. PubMed ID: 18079394
[TBL] [Abstract][Full Text] [Related]
2. Effects of oncogenic p110alpha subunit mutations on the lipid kinase activity of phosphoinositide 3-kinase.
Carson JD; Van Aller G; Lehr R; Sinnamon RH; Kirkpatrick RB; Auger KR; Dhanak D; Copeland RA; Gontarek RR; Tummino PJ; Luo L
Biochem J; 2008 Jan; 409(2):519-24. PubMed ID: 17877460
[TBL] [Abstract][Full Text] [Related]
3. Functional differences between two classes of oncogenic mutation in the PIK3CA gene.
Chaussade C; Cho K; Mawson C; Rewcastle GW; Shepherd PR
Biochem Biophys Res Commun; 2009 Apr; 381(4):577-81. PubMed ID: 19233141
[TBL] [Abstract][Full Text] [Related]
4. A specific function for phosphatidylinositol 3-kinase alpha (p85alpha-p110alpha) in cell survival and for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in de novo DNA synthesis of human colon carcinoma cells.
Bénistant C; Chapuis H; Roche S
Oncogene; 2000 Oct; 19(44):5083-90. PubMed ID: 11042696
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic mutations weaken the interactions that stabilize the p110α-p85α heterodimer in phosphatidylinositol 3-kinase α.
Echeverria I; Liu Y; Gabelli SB; Amzel LM
FEBS J; 2015 Sep; 282(18):3528-42. PubMed ID: 26122737
[TBL] [Abstract][Full Text] [Related]
6. The SH3 and BH domains of the p85alpha adapter subunit play a critical role in regulating class Ia phosphoinositide 3-kinase function.
Beeton CA; Das P; Waterfield MD; Shepherd PR
Mol Cell Biol Res Commun; 1999 May; 1(2):153-7. PubMed ID: 10356365
[TBL] [Abstract][Full Text] [Related]
7. Exploring the PI3K alpha and gamma binding sites with 2,6-disubstituted isonicotinic derivatives.
Cherian PT; Koikov LN; Wortman MD; Knittel JJ
Bioorg Med Chem Lett; 2009 Apr; 19(8):2215-9. PubMed ID: 19297156
[TBL] [Abstract][Full Text] [Related]
8. Frequent mutation of the PIK3CA gene in ovarian and breast cancers.
Levine DA; Bogomolniy F; Yee CJ; Lash A; Barakat RR; Borgen PI; Boyd J
Clin Cancer Res; 2005 Apr; 11(8):2875-8. PubMed ID: 15837735
[TBL] [Abstract][Full Text] [Related]
9. SH3 domain of the phosphatidylinositol 3-kinase regulatory subunit is responsible for the formation of a sequestration complex with insulin receptor substrate-1.
Ikegami Y; Inukai K; Awata T; Asano T; Katayama S
Biochem Biophys Res Commun; 2008 Jan; 365(3):433-8. PubMed ID: 17991427
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit.
Miled N; Yan Y; Hon WC; Perisic O; Zvelebil M; Inbar Y; Schneidman-Duhovny D; Wolfson HJ; Backer JM; Williams RL
Science; 2007 Jul; 317(5835):239-42. PubMed ID: 17626883
[TBL] [Abstract][Full Text] [Related]
11. Cloning, expression, purification, and characterization of the human Class Ia phosphoinositide 3-kinase isoforms.
Meier TI; Cook JA; Thomas JE; Radding JA; Horn C; Lingaraj T; Smith MC
Protein Expr Purif; 2004 Jun; 35(2):218-24. PubMed ID: 15135396
[TBL] [Abstract][Full Text] [Related]
12. Insights into the oncogenic effects of PIK3CA mutations from the structure of p110alpha/p85alpha.
Huang CH; Mandelker D; Gabelli SB; Amzel LM
Cell Cycle; 2008 May; 7(9):1151-6. PubMed ID: 18418043
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.
Horn S; Bergholz U; Jücker M; McCubrey JA; Trümper L; Stocking C; Bäsecke J
Oncogene; 2008 Jul; 27(29):4096-106. PubMed ID: 18317450
[TBL] [Abstract][Full Text] [Related]
14. Regulation of lipid binding underlies the activation mechanism of class IA PI3-kinases.
Hon WC; Berndt A; Williams RL
Oncogene; 2012 Aug; 31(32):3655-66. PubMed ID: 22120714
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic PI3K deregulates transcription and translation.
Bader AG; Kang S; Zhao L; Vogt PK
Nat Rev Cancer; 2005 Dec; 5(12):921-9. PubMed ID: 16341083
[TBL] [Abstract][Full Text] [Related]
16. Cancer-derived mutations in the regulatory subunit p85alpha of phosphoinositide 3-kinase function through the catalytic subunit p110alpha.
Sun M; Hillmann P; Hofmann BT; Hart JR; Vogt PK
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15547-52. PubMed ID: 20713702
[TBL] [Abstract][Full Text] [Related]
17. NMR solution structure of subunit F of the methanogenic A1AO adenosine triphosphate synthase and its interaction with the nucleotide-binding subunit B.
Gayen S; Vivekanandan S; Biuković G; Grüber G; Yoon HS
Biochemistry; 2007 Oct; 46(42):11684-94. PubMed ID: 17910473
[TBL] [Abstract][Full Text] [Related]
18. Structure of the whole cytosolic region of ATP-dependent protease FtsH.
Suno R; Niwa H; Tsuchiya D; Zhang X; Yoshida M; Morikawa K
Mol Cell; 2006 Jun; 22(5):575-85. PubMed ID: 16762831
[TBL] [Abstract][Full Text] [Related]
19. Architecture of mammalian fatty acid synthase at 4.5 A resolution.
Maier T; Jenni S; Ban N
Science; 2006 Mar; 311(5765):1258-62. PubMed ID: 16513975
[TBL] [Abstract][Full Text] [Related]
20. Multiple domains of Ruk/CIN85/SETA/CD2BP3 are involved in interaction with p85alpha regulatory subunit of PI 3-kinase.
Borthwick EB; Korobko IV; Luke C; Drel VR; Fedyshyn YY; Ninkina N; Drobot LB; Buchman VL
J Mol Biol; 2004 Oct; 343(4):1135-46. PubMed ID: 15476827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
